Literature DB >> 10560661

In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines.

L Minghetti1, D T Walsh, G Levi, V H Perry.   

Abstract

To clarify the role played by prostaglandins in acute brain inflammation we studied the expression of the key enzyme in their formation, cyclooxygenase-2 (COX-2), following microinjection of bacterial endotoxin (LPS), interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma), in the rat dorsal hippocampus. In spite of the extensive astrocyte and microglial reaction, at 24 hours after LPS injection COX-2 immunoreactivity (COX-2-ir) was exclusively associated with infiltrating neutrophils and with perivascular cells of blood vessels in the area surrounding the injection site. Microinjection of IFN-gamma did not alter COX-2-ir, whereas TNF-alpha or IL-1beta injection induced a moderate COX-2-ir in the perivascular cells of a few blood vessels close to the injection site, and in very few of the infiltrating neutrophils. When IL-1beta, but not TNF-alpha or INF-gamma, was injected in combination with LPS, a strong COX-2-ir was associated with the perivascular cells of most blood vessels in the injected hemisphere and of several of those in the uninjected hemisphere. In addition, COX-2-ir was detected in neutrophils and in several parenchymal cells surrounding the injection site. The parenchymal and perivascular COX-2-positive cells showed a microglia/macrophage-like morphology, as compared with the GSI-B4 isolectin and ED-1 staining, specific for macrophages. Since the constitutive neuronal COX-2 was not affected by any of the conditions studied, the macrophage-like cells found in the perivascular region and in the parenchyma may represent the main source of prostaglandins during focal inflammatory responses in the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560661     DOI: 10.1097/00005072-199911000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

1.  Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells.

Authors:  S E Park; K Sapkota; S Kim; H Kim; S J Kim
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Phlorofucofuroeckol A suppresses expression of inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines via inhibition of nuclear factor-κB, c-Jun NH2-terminal kinases, and Akt in microglial cells.

Authors:  A-Reum Kim; Min-Sup Lee; Ji-Woong Choi; Tadanobu Utsuki; Jae-Il Kim; Byeong-Churl Jang; Hyeung-Rak Kim
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

3.  YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia.

Authors:  D-Y Lu; C-H Tang; H-C Liou; C-M Teng; K-C G Jeng; S-C Kuo; F-Y Lee; W-M Fu
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

4.  Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Rudra P Ojha; Manisha Rastogi; B Parimala Devi; Aruna Agrawal; G P Dubey
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-21       Impact factor: 4.147

Review 5.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

6.  Interleukin-6 induces prostaglandin E(2) synthesis in mouse astrocytes.

Authors:  Toshiyuki Chikuma; Tetsuya Yoshimoto; Masahiro Ohba; Makoto Sawada; Takeshi Kato; Tomoaki Sakamoto; Yukio Hiyama; Hiroshi Hojo
Journal:  J Mol Neurosci       Date:  2009-03-10       Impact factor: 3.444

7.  Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction.

Authors:  Kimberly D P Hammer; Matthew L Hillwig; Jeffrey D Neighbors; Young-Je Sim; Marian L Kohut; David F Wiemer; Eve S Wurtele; Diane F Birt
Journal:  Phytochemistry       Date:  2008-08-15       Impact factor: 4.072

Review 8.  Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.

Authors:  Hironori Yokoyama; Hayato Kuroiwa; Ryohei Yano; Tsutomu Araki
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

Review 9.  The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.

Authors:  Garima Dutta; Ping Zhang; Bin Liu
Journal:  Fundam Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.748

10.  Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.

Authors:  Hironori Yokoyama; Ryohei Yano; Eriko Aoki; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.